Elekta Unity enables us to test more ambitious strategies for prostate cancer treatment so we may cure prostate cancer in just two fractions.
MR-guided radiation therapy for prostate cancer
Reduce margins. Reduce fractions. Preserve function.
Continuous MR imaging reveals just how much the prostate moves and changes shape between and during fractions. This mobility challenges treatment accuracy and precision. While margins account for uncertainties, irradiation of healthy tissue can result in toxicity and associated side effects.
Elekta Unity MR guided radiation therapy allows you to see the prostate and surrounding organs clearly as you treat, enabling you to respond to change and motion, and to adapt the plan for each patient and every fraction. With Elekta Unity you can:
Reduce margins with certainty. Reduce number of fractions to 5. Preserve quality of life and erectile function.
Clinical benefits
Elekta Unity MR-guided radiation therapy for prostate cancer
Elekta Unity allows clinicians to treat even the most challenging prostate SBRT cases with low toxicity.
- Use smaller margins to spare OARs and reduce toxicity
- Complete prostate SBRT in 5 fractions or less
- Increase efficiency with fiducial/spacer-free treatments
- Enhance patient comfort with shorter courses and fewer side effects
- Personalize treatments with advanced imaging capabilities
See the difference for prostate cancer treatments
Prostate SBRT in just 2 fractions
Elekta Unity leads the way to ultra-hypofractionation. Where five fraction SBRT is standard on Unity, preliminary findings from the HERMES trial highlight that low levels of acute toxicity are also achieved with two-fraction MR-guided adaptive SBRT in men with intermediate or lower high-risk prostate cancer.
Safeguard erectile function
Elekta Unity prioritizes the preservation of erectile function with exquisite soft tissue visualization and online adaptation to spare the neurovascular bundle and internal pudendal arteries.
Account for intrafraction drift
Elekta Unity addresses intrafraction drift by providing real-time visualization of the prostate during treatment. Detection and rapid correction of significant drift, caused by e.g. bladder filling or patient relaxation, leads to reduced toxicity and improved efficiency.
Escalate dose to tumor
Superior sub-structural image quality with Elekta Unity allows the tumor to be clearly visualized, providing the possibility of dose escalation to tumor cells within the prostate rather than treating the entire organ.
Image courtesy of Odense University Hospital
Clinical evidence
Learn more how Unity is benefiting prostate cancer patients
ERECT trial
The ERECT trial aims to show preserved erectile function in prostate cancer patients treated with nerve- and vascular-sparing MR-guided radiation therapy.
Clinical trial
Elekta Unity overview and technical publication
Bibliography
Elekta Unity clinical indications
Bibliography
Elekta Unity Biology-guided radiation therapy
Bibliography
Elekta Unity workflow and usability
Bibliography
Find out more about
Elekta Unity
More than confident—certain
Elekta Unity
Indications
Explore the benefits of Elekta Unity for highlighted indications
Take lead
In Prostate Cancer Care
Experience the future of radiation therapy today. Request a demo or consultation to learn how Elekta Unity can transform your prostate cancer treatment outcomes.